327 related articles for article (PubMed ID: 16249080)
1. Pregnancy, progesterone and progestins in relation to breast cancer risk.
Campagnoli C; Abbà C; Ambroggio S; Peris C
J Steroid Biochem Mol Biol; 2005 Dec; 97(5):441-50. PubMed ID: 16249080
[TBL] [Abstract][Full Text] [Related]
2. Progestins and progesterone in hormone replacement therapy and the risk of breast cancer.
Campagnoli C; Clavel-Chapelon F; Kaaks R; Peris C; Berrino F
J Steroid Biochem Mol Biol; 2005 Jul; 96(2):95-108. PubMed ID: 15908197
[TBL] [Abstract][Full Text] [Related]
3. Hormone replacement therapy and risk of breast cancer: the role of progestins.
Stahlberg C; Pedersen AT; Lynge E; Ottesen B
Acta Obstet Gynecol Scand; 2003 Apr; 82(4):335-44. PubMed ID: 12716318
[TBL] [Abstract][Full Text] [Related]
4. Epidemiologic aspects of exogenous progestagens in relation to their role in pathogenesis of human breast cancer.
van Leeuwen FE
Acta Endocrinol (Copenh); 1991; 125 Suppl 1():13-26. PubMed ID: 1801500
[TBL] [Abstract][Full Text] [Related]
5. Progesterone vs. synthetic progestins and the risk of breast cancer: a systematic review and meta-analysis.
Asi N; Mohammed K; Haydour Q; Gionfriddo MR; Vargas OL; Prokop LJ; Faubion SS; Murad MH
Syst Rev; 2016 Jul; 5(1):121. PubMed ID: 27456847
[TBL] [Abstract][Full Text] [Related]
6. Hormone replacement therapy use and variations in the risk of breast cancer.
Opatrny L; Dell'Aniello S; Assouline S; Suissa S
BJOG; 2008 Jan; 115(2):169-75; discussion 175. PubMed ID: 18081598
[TBL] [Abstract][Full Text] [Related]
7. The bioidentical hormone debate: are bioidentical hormones (estradiol, estriol, and progesterone) safer or more efficacious than commonly used synthetic versions in hormone replacement therapy?
Holtorf K
Postgrad Med; 2009 Jan; 121(1):73-85. PubMed ID: 19179815
[TBL] [Abstract][Full Text] [Related]
8. Progestagen component in combined hormone replacement therapy in postmenopausal women and breast cancer risk: a debated clinical issue.
Gadducci A; Biglia N; Cosio S; Sismondi P; Genazzani AR
Gynecol Endocrinol; 2009 Dec; 25(12):807-15. PubMed ID: 19906000
[TBL] [Abstract][Full Text] [Related]
9. Progesterone, progestins, and the heart.
Bernstein P; Pohost G
Rev Cardiovasc Med; 2010; 11(3):e141-9. PubMed ID: 21045766
[TBL] [Abstract][Full Text] [Related]
10. Progesterone or progestin as menopausal ovarian hormone therapy: recent physiology-based clinical evidence.
Prior JC
Curr Opin Endocrinol Diabetes Obes; 2015 Dec; 22(6):495-501. PubMed ID: 26512775
[TBL] [Abstract][Full Text] [Related]
11. Disruption of androgen receptor signaling by synthetic progestins may increase risk of developing breast cancer.
Birrell SN; Butler LM; Harris JM; Buchanan G; Tilley WD
FASEB J; 2007 Aug; 21(10):2285-93. PubMed ID: 17413000
[TBL] [Abstract][Full Text] [Related]
12. Micronized progesterone and its impact on the endometrium and breast vs. progestogens.
Gompel A
Climacteric; 2012 Apr; 15 Suppl 1():18-25. PubMed ID: 22432812
[TBL] [Abstract][Full Text] [Related]
13. Effects of estradiol with micronized progesterone or medroxyprogesterone acetate on risk markers for breast cancer in postmenopausal monkeys.
Wood CE; Register TC; Lees CJ; Chen H; Kimrey S; Cline JM
Breast Cancer Res Treat; 2007 Jan; 101(2):125-34. PubMed ID: 16841178
[TBL] [Abstract][Full Text] [Related]
14. Micronized progesterone, progestins, and menopause hormone therapy.
Hipolito Rodrigues MA; Gompel A
Women Health; 2021 Jan; 61(1):3-14. PubMed ID: 32957843
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer risk during hormone therapy: experimental versus clinical data.
Ruan X; Seeger H; Mueck AO
Minerva Endocrinol; 2012 Mar; 37(1):59-74. PubMed ID: 22382615
[TBL] [Abstract][Full Text] [Related]
16. Progestins and breast cancer.
Eden J
Am J Obstet Gynecol; 2003 May; 188(5):1123-31. PubMed ID: 12748456
[TBL] [Abstract][Full Text] [Related]
17. Progesterone, progestins and the breast in menopause treatment.
Gompel A; Plu-Bureau G
Climacteric; 2018 Aug; 21(4):326-332. PubMed ID: 29852797
[TBL] [Abstract][Full Text] [Related]
18. Progesterone, progestins, pregnancy and breast cancer risk.
Ferretti G
Breast Cancer Res Treat; 2007 Jul; 103(3):373-4. PubMed ID: 17063269
[No Abstract] [Full Text] [Related]
19. In Defense of Progesterone: A Review of the Literature.
Lieberman A; Curtis L
Altern Ther Health Med; 2017 Nov; 23(6):24-32. PubMed ID: 29055286
[TBL] [Abstract][Full Text] [Related]
20. Is breast cancer risk the same for all progestogens?
Stute P
Arch Gynecol Obstet; 2014 Aug; 290(2):207-9. PubMed ID: 24838289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
